Patents by Inventor Franck Artzner

Franck Artzner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ELASTOMERIC POLYMER MATERIAL WITH SHAPE MEMORY PROPERTIES AND METHOD FOR PREPARING SUCH A MATERIAL
    Publication number: 20230406998
    Abstract: The invention relates to a method for preparing a polyester polymer material, which comprises preparing a reaction medium comprising a mixture of at least one monomer chosen from ?-hydroxylated fatty acids and ?-hydroxylated fatty acid esters of an alcohol comprising an aliphatic chain comprising from 1 to 18 carbon atoms, and at least one phenolic compound, the total content of phenolic compound(s) being within a range of values from 0.3 to 42 mg equivalent of gallic acid per gram of the mixture. The method then comprises heating this reaction medium in order to carry out the polymerisation of the monomer and the phenolic compound and the cross-linking of the polymer thus formed.
    Type: Application
    Filed: November 22, 2021
    Publication date: December 21, 2023
    Inventors: Bénédicte BAKAN, Didier MARION, Denis LOURDIN, Mathilde MARC, Christelle LOPEZ, Eric LEROY, Franck ARTZNER
  • Octapeptide compounds derived from somatostatin and the therapeutic use thereof
    Patent number: 9382306
    Abstract: The present invention relates to novel octapeptide compounds of general formula (I): H-2-Nal 1-cyclo(Cys2-Tyr3-AA4-Lys5-Val6-Cys7)-Thr8-NH2. Since these products have a good affinity for certain somatostatin receptor subtypes, they are particularly advantageous for treating pathological states or diseases in which one (or more) somatostatin receptor(s) is (are) involved. These compounds furthermore have physiochemical properties that make it possible to envisage them in diverse solutions for the formulation of medicaments, for example as a pharmaceutically acceptable carrier. The invention also relates to pharmaceutical compositions containing said products and to the use thereof for the preparation of a medicament.
    Type: Grant
    Filed: September 29, 2009
    Date of Patent: July 5, 2016
    Assignees: IPSEN PHARMA S.A.S., COMMISSARIAT A L'ENERGIE ATOMIQUE (CEA), LE CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Marie-Thérèse Paternostre, Jean-Christophe Cintrat, Céline Valery, Stéphane Roux, Bernard Rousseau, Maarten Ijsselstijn, Roland Cherif-Cheikh, Franck Artzner
  • AQUEOUS SUSTAINED RELEASE COMPOSITIONS OF LHRH ANALOGUES
    Publication number: 20160184386
    Abstract: An aqueous pharmaceutical composition for the sustained release of an LHRH analogue, in particular for a sustained release compatible with therapeutic treatments for at least 2 weeks. The pharmaceutical compositions are particularly useful for the treatment of diseases an LHRH analogue is indicated for.
    Type: Application
    Filed: July 21, 2014
    Publication date: June 30, 2016
    Inventors: Joel RICHARD, Anne PETIT, Jeremiah HARNETT, Marie-Madeleine BARONNET, Franck ARTZNER, Mercedes CARDUS MALESPINA, Roland CHERIF-CHEIKH, Martin MONTES, Marie-Therese PATERNOSTRE, Celine VALERY
  • Octapeptide compounds and therapeutic use thereof
    Patent number: 9040482
    Abstract: The present invention relates to novel octapeptide compounds of general formula (I), R-AA1-cyclo(AA2-Tyr3-D-Trp4-AA5-Val6-Cys7)-Thr8-NH2??(I) As these products have a good affinity for certain sub-types of somatostatin receptors, they are particularly useful for treating the pathological states or diseases in which one (or more) of the somatostatin receptors is (are) involved. The invention also relates to pharmaceutical compositions containing said products and their use for the preparation of a medicament.
    Type: Grant
    Filed: June 21, 2011
    Date of Patent: May 26, 2015
    Assignees: IPSEN PHARMA S.A.S., COMMISSARIAT A L'ENERGIE ATOMIQUE (C.E.A.), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.)
    Inventors: Jean-Christophe Cintrat, Melinda Ligeti, Bernard Rousseau, Franck Artzner, Christophe Tarabout, Marie-Thérèse Paternostre, Nicolas Fay, Roland Cherif-Cheikh, Céline Valery
  • NOVEL OCTAPEPTIDE COMPOUNDS AND THERAPEUTIC USE THEREOF
    Publication number: 20130252892
    Abstract: The present invention relates to novel octapeptide compounds of general formula (I), R-AA1-cyclo(AA2-Tyr3-D-Trp4-AA5-Val6-Cys7)-Thr8-NH2??(I) As these products have a good affinity for certain sub-types of somatostatin receptors, they are particularly useful for treating the pathological states or diseases in which one (or more) of the somatostatin receptors is (are) involved. The invention also relates to pharmaceutical compositions containing said products and their use for the preparation of a medicament.
    Type: Application
    Filed: June 21, 2011
    Publication date: September 26, 2013
    Applicant: IPSEN PHARMA S.A.S
    Inventors: Jean-Christophe Cintrat, Melinda Ligeti, Bernard Rousseau, Franck Artzner, Christophe Tarabout, Marie-Thérèse Paternostre, Nicolas Fay, Roland Cherif-Cheikh, Céline Valery